Trial Profile
Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 10 Dec 2012
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 10 Dec 2012 New trial record